Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HyperSpeed LASIK is a branded laser vision correction procedure marketed primarily by LASIK MD, utilizing the Alcon WaveLight EX500 Excimer Laser platform. The "HyperSpeed" designation refers to the laser's industry-leading 500 Hz pulse frequency, which enables the correction of one diopter of vision in approximately 1.4 seconds. This high-speed performance minimizes the duration of the surgical procedure, reduces the risk of stromal dehydration, and improves overall clinical outcomes for patients. The technology is designed to treat a wide range of refractive errors, including nearsightedness, farsightedness, and astigmatism. As a commercialized healthcare service, HyperSpeed LASIK represents a high-efficiency standard in modern refractive surgery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HyperSpeed LASIK.